Acute Telogen Effluvium: A Post-Covid-19 Sequela

April 2023 in “ Clinical dermatology review ”

Mohan Eshwar Rao Shendre, Sanjay Ramachandra Thejaswi, Chanabasappa Mendagudli, Vrinda Nair, Supriya Rajesh

telogen effluvium hair loss COVID-19 excessive shedding thinning of hair scalp TE

Studysummary This study found that 72% of patients who recovered from COVID-19 during the second wave reported experiencing significant hair loss, characteristic of telogen effluvium.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on journals.lww.com →

Discuss this study in the Community →

Research cited in this study

9 / 9 results

research A Systematic Review of Acute Telogen Effluvium, a Harrowing Post-COVID-19 Manifestation

25 citations , December 2021 in “Journal of Medical Virology”

This systematic review reports that acute telogen effluvium may occur as a stress-induced hair loss following COVID-19 recovery, with most patients experiencing hair regrowth over time.

Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management

research Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management

39 citations , August 2021 in “JAAD International”

This study found that telogen effluvium and trichodynia are common in patients after COVID-19, and their severity may be influenced by the severity of the COVID-19 infection.

research Time of Onset and Duration of Post-COVID-19 Acute Telogen Effluvium

32 citations , July 2021 in “Journal of The American Academy of Dermatology”

This study found that acute telogen effluvium after COVID-19 typically began about 1.5 months post-infection and resolved sooner than typical cases, with most resolving in under two months.

research Telogen Effluvium Associated with COVID-19 Infection

44 citations , January 2021 in “Dermatologic Therapy”

This study suggests that COVID-19 infection may trigger telogen effluvium, a condition of hair shedding, though medication side effects and pandemic-related stress cannot be excluded as contributing factors.

research Telogen Effluvium: A Sequela of COVID-19

58 citations , November 2020 in “International Journal of Dermatology”

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

research Telogen Effluvium Related to Post Severe SARS-CoV-2 Infection: Clinical Aspects and Our Management Experience

35 citations , November 2020 in “Dermatologic Therapy”

This case series reports telogen effluvium in three patients following severe Sars-Cov-2 infection and suggests a potential association that merits further investigation.

research Management of Telogen Effluvium During the COVID-19 Emergency: Psychological Implications

31 citations , May 2020 in “Dermatologic Therapy”

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

research An Overview of Alopecias

53 citations , March 2014 in “Cold Spring Harbor Perspectives in Medicine”

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

research Diffuse Hair Loss in an Adult Female: Approach to Diagnosis and Management

70 citations , January 2009 in “Indian Journal of Dermatology, Venereology and Leprology”

This article reviews the characteristics, diagnosis, and management of different types of diffuse alopecia in women and provides no original research findings.